Castle Biosciences paid its 4 named executives $13.9M in total in FY2025 (Dec). CEO Derek J. Maetzold was paid $6.8M of that.
Pay$100 in the stock at the end of FY20 → $58
Pay of each named executive
Derek J. MaetzoldPresident and CEO
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Frank StokesChief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Kristen M. OelschlagerChief Operating Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Tobin W. JuvenalChief Commercial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
CEO pay against the pay peers
In FY2024 (Dec), the median CEO pay of the 8 peers with pay on file was $8.6M. The CEO of Castle Biosciences was paid $6.9M, 19% below the median.
- 1Natera
- 2Neogenomics
- 3CareDx
- 4Pacific Biosciences Of California
- 5Adma Biologics
- 6Twist Bioscience
- 7Castle BiosciencesThis company
- 8Veracyte
- 9Adaptive Biotechnologies
- 10Axonics, Inc.Not disclosed
- 11Biocryst PharmaceuticalsNot disclosed
- 12Guardant HealthNot disclosed
- 13Invitae CorporationNot disclosed
- 14Mesa Laboratories Inc /Co/Not disclosed
- 15OraSure Technologies, Inc.Not disclosed
- 16Quanterix CorporationNot disclosed
- 17Silk Road Medical, Inc.Not disclosed
- 18iRhythm Technologies, Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.